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Abstract
Faster growing and more virulent strains of methicillin resistant Staphylococcus aureus (MRSA) are increasingly displacing
highly resistant MRSA. Elevated fitness in these MRSA is often accompanied by decreased and heterogeneous levels of
methicillin resistance; however, the mechanisms for this phenomenon are not yet fully understood. Whole genome
sequencing was used to investigate the genetic basis of this apparent correlation, in an isogenic MRSA strain pair that
differed in methicillin resistance levels and fitness, with respect to growth rate. Sequencing revealed only one single
nucleotide polymorphism (SNP) in the diadenylate cyclase gene dacA in the faster growing but less resistant strain.
Diadenylate cyclases were recently discovered to synthesize the new second messenger cyclic diadenosine monophosphate
(c-di-AMP). Introduction of this mutation into the highly resistant but slower growing strain reduced resistance and
increased its growth rate, suggesting a direct connection between the dacA mutation and the phenotypic differences of
these strains. Quantification of cellular c-di-AMP revealed that the dacA mutation decreased c-di-AMP levels resulting in
reduced autolysis, increased salt tolerance and a reduction in the basal expression of the cell wall stress stimulon. These
results indicate that c-di-AMP affects cell envelope-related signalling in S. aureus. The influence of c-di-AMP on growth rate
and methicillin resistance in MRSA indicate that altering c-di-AMP levels could be a mechanism by which MRSA strains can
increase their fitness levels by reducing their methicillin resistance levels.
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Introduction
Infections with methicillin resistant Staphylococcus aureus (MRSA)
have severely impaired treatment outcomes and are cost intensive
for the healthcare system. MRSA contain a staphylococcal cassette
chromosome mec (SCCmec) element harbouring the mecA gene that
codes for an alternative penicillin binding protein, PBP2a, which
confers resistance to beta-lactams, the antibiotic class of first choice
for treating S. aureus infections. Initially, MRSA were restricted to
healthcare settings with high antibiotic pressure. These healthcare-
associated (HA)-MRSA strains generally displayed low heteroge-
neous resistance profiles, whereby only small subpopulations could
survive at high beta-lactam concentrations. Over time, HA-MRSA
strains possessing very high beta-lactam minimum inhibitory
concentrations (MICs) emerged, such as E-MRSA 16 (ST32-
MRSA-II) or the Iberian clone (ST247-MRSA-I), which success-
fully spread in hospitals all over the world (for reviews see [1,2]).
Over the last fifteen years MRSA have started to spread in the
community [3]. These so-called community-acquired (CA)-MRSA
are characteristically fitter and more virulent than HA-MRSA
strains (for reviews see [4,5]). CA-MRSA strains, such as USA300,
are capable of infecting healthy individuals without obvious risk
factors [3]. CA-MRSA typically have relatively low oxacillin
MICs, but their heterogeneous resistance profiles include higher-
resistant subpopulations of bacteria that can cause treatment
failure. CA-MRSA-like clones are increasingly displacing conven-
tional, previously successful, HA-MRSA clones in hospitals [6].
Methicillin resistance does not only depend on PBP2a
production but it is also affected by the genetic background of a
strain [7] and factors influencing methicillin resistance, previously
called fem (factors essential for methicillin resistance) or aux
(auxiliary) factors [8,9,10]. These factors are often directly or
indirectly involved in cell envelope biosynthesis and turnover.
Examples of fem/aux factors linked to the cell envelope include cell
wall biosynthesis enzymes like GlmM [11], MurE [12], MurF [13],
FemABX [14], PBP2 [15], PBP4 [16]; and wall teichoic acid
biosynthesis enzymes including TagO/TarO [17], the dlt operon
[18] and the wall teichoic acid ligase MsrR [19,20]. Fem/aux
factors indirectly connected or with no obvious connection to the
cell envelope include regulators like SigB [21], SpoVG [22], agr
[23], SarA [23], XdrA [24], CcpA [25], SecDF [26] or two
component systems like VraSR [27,28].
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Recently, a new second messenger, cyclic diadenosine mono-
phosphate (c-di-AMP) was shown to influence methicillin
resistance in S. aureus [29]. Second messengers are small molecules
such as the nucleotides cAMP, cGMP, c-di-GMP or (p)ppGpp that
regulate various cellular processes including virulence, biofilm
formation, motility and the cell cycle. Levels of the nucleotide
(p)ppGpp, involved in the stringent response, were also recently
discovered to influence beta-lactam resistance [30]. Regulation by
nucleotides can occur at transcriptional, translational and post
translational levels (for reviews see [31,32]). c-di-AMP is synthe-
sized by condensation of two ATP molecules by diadenylate
cyclase domain (DAC) proteins and was first identified by Witte et
al. in Bacillus subtilis in 2008 [33]. In contrast to B. subtilis, which
has three different proteins with DAC domains, S. aureus possesses
only one DAC domain protein, DacA. DacA is claimed to be
essential and shows a similar structure to the B. subtilis DAC
domain protein CdaA (previously called YbbP) containing a
transmembrane domain and the DAC domain [29]. Additionally,
the genetic regions of S. aureus and B. subtilis have a similar
organisation forming the three-gene operons dacA-ybbR-glmM and
cdaA-cdaR-glmM, respectively, including the phosphoglucosamine
mutase glmM and the recently identified c-di-AMP regulator cdaR
or its S. aureus homologue ybbR [11,34]. However, in B. subtilis the
glucosamine-6-phosphate synthase gene glmS is located directly
downstream of glmM and forms an additional large transcript cdaA-
ybbR-glmM-glmS [34]. In contrast, glmS in S. aureus is separated from
glmM by about 14 kb, which contains the cell wall associated
protein fmtB (also called mrp) and mannitol synthesis and export
genes [35]. A larger transcript including fmtB but not glmS has been
detected in S. aureus (dacA-ybbR-glmM-fmtB) [36]. In B. subtilis the
protein encoded directly upstream of the diadenylate cyclase,
CdaR (previously called YbbR), is a c-di-AMP synthase regulator
which was found to specifically stimulate c-di-AMP production by
CdaA [34]. Mehne and colleagues suggested that the same positive
regulation could occur by YbbR of S. aureus since DacA and CdaA
share several common features, as described above. The cellular
level of c-di-AMP is further influenced by degradation of c-di-
AMP to 5’-pApA by the phosphodiesterase GdpP [29,37]. In
several studies, mutations in gdpP were found to increase resistance
or tolerance to beta-lactam antibiotics in B. subtilis, Listeria
monocytogenes and S. aureus by as yet unknown mechanisms
[29,38,39,40,41,42]. Besides antibiotic resistance, c-di-AMP
affects cell envelope homeostasis in both B. subtilis and S. aureus
[29,40]. In S. aureus a 15-fold increased c-di-AMP level led to
increased peptidoglycan cross-linking and could compensate for
the absence of lipoteichoic acids [29]. Interestingly, c-di-AMP
secreted from L. monocytogenes triggers a host type I interferon
response; a c-di-AMP dependent type I interferon response was
also detected in the Gram-negative Chlamydia trachomatis [43,44].
Furthermore, a gdpP mutation in Lactococcus lactis led to salt
hypersensitivity and heat resistance [45].
Very recently the first c-di-AMP receptors were identified
[46,47]. One is the TetR-like transcription factor DarR of
Mycobacterium smegmatis [47] and four receptor proteins were
identified in S. aureus; the potassium transporter-gating component
KtrA, a predicted cation/proton antiporter CpaA, a PII-like signal
transduction protein PstA and a histidine kinase KdpD [46].
However, it remains unclear how these c-di-AMP receptors
influence cell envelope homeostasis and beta-lactam resistance,
indicating that there might be more receptors.
Even though there has been extensive research on methicillin
resistance, the mechanisms governing heterogeneous and homo-
geneous resistance in MRSA are not completely understood yet. In
our study we analysed an isogenic MRSA strain pair differing in
fitness and methicillin resistance levels. Whole genome sequencing
identified only one single nucleotide polymorphism (SNP) which
was in the diadenylate cyclase gene dacA. Markerless allelic
replacement was used to confirm that this mutation was
responsible for the transition from homogeneous to heterogeneous
resistance and the associated faster growth rate. Quantification of
cellular c-di-AMP levels indicated that phenotypic changes were
caused by decreased c-di-AMP, due to the dacA-SNP.
Materials and Methods
Bacterial strains and growth conditions
The strains and plasmids used in this study are listed in Table 1.
Bacteria were grown at 37uC in Luria Bertani (LB) broth (Difco
Laboratories, Detroit, MI, USA), shaking at 180 rpm with a 1:5
culture to air ratio, or on LB agar plates unless indicated
differently. Optical density (OD) was measured at 600 nm. Media
were supplemented with the following antibiotics when appropri-
ate: 10 mg/ml tetracycline (Sigma, St. Lousis, MO, USA), 10 mg/
ml chloramphenicol (Sigma), 100 mg/ml ampicillin (Sigma),
200 ng/ml anhydrotetracycline (Sigma) or various concentrations
of oxacillin (InfectoPharm, Heppenheim, Germany).
Whole genome sequencing and data analysis
Genome sequencing of strains RA120 and ME51 was
performed by GATC Biotech AG (Konstanz, Germany) on an
Illumina HiSeq 2000 (Illumina Inc., Saffron Walden, United
Kingdom). Mapping of the 31-bp reads of a 200-bp paired-end
library against the reference genome NCTC8325 and SNP calling
was performed with the CLC Genomics workbench 4.8 (CLC Bio,
Aarhus, Denmark), resulting in 63-fold mean depth coverage for
RA120 (6’135’387 reads) and 83-fold mean depth coverage for
ME51 (7’658’818 reads). The parent strain BB255 was sequenced
using a PacBio RS SMRT sequencer (Pacific Biosciences Inc.,
Menlo Park, CA, USA) at the Functional Genomics Center
Zurich. DNA from standard phenol/chloroform/isoamyl alcohol
extractions was purified over DNeasy Mini Spin Columns
(Qiagen, Du¨sseldorf, Germany). Two 250-bp libraries and one
6-kb library were prepared with the PacBio C1 chemistry kits
provided by Pacific Biosciences according to the manufacturers’
recommendations. The library was quality inspected and quanti-
fied on the Agilent Bioanalyzer (Agilent Technologies, Santa
Clara, CA, USA) and on a Qubit Fluorometer (Life technologies
Europe, Zug, Switzerland), respectively. After the run, sequencing
reports were generated via the SMRT portal to assess the adapter
dimer contamination, the sample loading efficiency, the obtained
average read length and the number of filtered sub-reads.
Mapping of the sub-reads against the reference genome
NCTC8325 and SNP calling was performed automatically via
the SMRT portal and confirmed using CLC Genomics Work-
bench 4.8. A 174-fold mean depth coverage from 1’978’548 reads
with an average read length of 199 bp from the 250-bp libraries
and 126’945 reads with an average read length of 981 bp including
reads reaching up to 17’000 bp from the 6-kb library were
achieved. The sequencing data was submitted to the European
Nucleotide Archive (ENA) under the study accession number
PRJEB400 and the sample accession numbers ERS251419
(BB255), ERS251420 (RA120) and ERS251421 (ME51).
Resequencing and construction of mutant strains
The identified SNP in dacA was confirmed by Sanger
sequencing with the primers 2407.F (TTATTTCA-
CACCTTTCTTTTGAAAG) and 2407.R (ATGGATTTTTC-
CAACTTTTTTCAAA) at Mircosynth (Balgach, Switzerland).
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The pKOR1 system developed by Bae & Schneewind was used to
insert the mutation into dacA by homologous recombination [48].
The dacA gene, with additional 1000-bp upstream and 1020-bp
downstream regions, was amplified from genomic DNA of strain
ME51 using primers attB1-2407-upF (GGGG ACAAGTTTG-
TACAAAAAAGCAGGCT CGACACCTCTTACTCCGTCT)
and attB2-2407-downR (GGGG ACCACTTTGTACAA-
GAAAGCTGGGT ACCAACAGCAATTAGATATG) and the
fragment was recombined into the pKOR1 plasmid. Markerless
allelic replacement was then performed as previously described
[48].
Oxacillin population analysis profiles and determination
of oxacillin minimum inhibitory concentration (MIC)
Antibiotic resistance profiles were determined by plating
appropriate dilutions of an overnight culture, ranging from
undiluted to 1027, on increasing concentrations of oxacillin.
Plates were incubated at 37uC and colony forming units per ml
(CFU/ml) were determined after 48 hours. Experiments were
performed at least three times and representative data are shown.
MICs were determined using EtestH strips (BioMe´rieux, Marcy
l’Etoile, France) on Mueller-Hinton plates swabbed with an
inoculum of 0.5 McFarland and incubated at 37uC for 24 h. MICs
tests were performed at least three times.
Autolysis
Spontaneous and induced autolysis were determined as
previously described [26]. Briefly, cells were grown to OD 0.7,
washed with 0.85% NaCl and resuspended in 0.01 M Na-
phosphate buffer pH 7. The OD was adjusted to 0.7, cultures
were incubated at 37uC and decreases in OD were measured over
time. For induced autolysis 0.01% Triton X-100 (Fluka, Buchs,
Switzerland) was added to the phosphate buffer after washing.
Values shown represent the means and standard deviation from
three independent experiments. For statistical analysis of individ-
ual time points Student’s t-tests were performed and for
comparison of whole data sets two-way Anova was applied.
PBP2a and PBP4 Western blot
S. aureus membrane fractions were obtained as described by
Quiblier et al. [26] and PBP2a Western blot analyses were
performed as described by Ender at al. [49]. Briefly, cells were
sampled by centrifugation and pellets were frozen in liquid
nitrogen then resuspended and lysed with lysostaphin, lysozyme
and DNase in SSM buffer (500 mM sucrose, 2 mM malate,
20 mM MgCl2, pH 6.8). After five cycles of freezing and thawing
the membrane fraction was obtained by centrifugation at 20’000 g
and resuspended in glycerol buffer (30% glycerol, 150 mM NaCl,
25 mM TrisHCl, 1 mM MgCl2, pH 7.5). Protein concentrations
were measured by Bradford assay (BioRad, Hercules, CA, USA)
and 10–20 mg of protein were separated on a SDS-7.5% PAGE for
PBP2a Western blots and 80 mg of protein were separated on a
SDS-12% PAGE for PBP4 Western blots. Gels were blotted onto
PVDF-membranes (Immobilon-P, Milipore, Billerica, MA, USA)
and the membranes were blocked with 5% milk powder and with
40 mg/ml human IgG (Calbiochem, Merck, Darmstadt, Ger-
many). PBP2a was detected using PBP2a antibodies (1:20’000,
Denka Seiken¸ Tokyo, Japan) and Horseradish Peroxidase-Conju-
gated (HRP) goat anti-mouse IgG (1:2500, Jackson ImmunoR-
esearch, West Grove, PA, USA). PBP4 was detected with PBP4
antibodies (1:2000, [50]) and goat anti-rabbit IgG HPR (1:5000,
Jackson ImmunoResearch). Signals were quantified using the
AlphaInnotech imager software (Santa Clara, CA, USA), loading
differences were corrected and values were given as a percentage
of the signal intensity of strain RA120 with standard deviation.
Student’s t-test was applied to determine the significance of any
differences. Western blot analyses were performed on three
independent protein extractions.
Table 1. Strains and plasmids.
Strain or plasmid name Relevant genotype and/or phenotype Source or reference
Strains
S. aureus
RN4220 Restriction-deficient derivative of NCTC 8325-4 [68]
BB255 NCTC8325 derivative, FK268 cured from plasmid pI524 by ethidium bromide
treatment, ST8, McS
[53]
RA120 BB255 containing SCCmec type I, McR [54]
ME51 RA120 derivative with increased fitness isolated from competition experiments,
mutation in DacA (Gly206Ser), McR
[54]
COL Clinical HA-MRSA, ST250, McR [9]
BB255::dacA-SNP BB255 with mutation in DacA (Gly206Ser), McS This study
RA120::dacA-SNP RA120 with mutation in DacA (Gly206Ser), McR This study
COL::dacA-SNP COL with mutation in DacA (Gly206Ser), McR This study
E. coli
DH5a F- w80d/acZDM15 recA1 Invitrogen
Plasmids
pKOR1 S. aureus-E. coli shuttle vector, ori pAMa1, ori ColE1, E. coli Amr, S. aureus Cmr [48]
pKOR1-dacA-SNP pKOR1 construct containing the dacA gene with 1000-bp upstream and 1020-bp
downstream regions carrying a mutation leading to Gly206Ser substitution in DacA
This study
psas016p-luc+ pBUS1 containing the sas016 promoter-luciferase reporter gene fusion [67]
Abbreviations: Am, ampicillin; Cm, chloramphenicol; Mc, methicillin; Tc, tetracycline; r, resistant; s, susceptible; ST, sequence type.
doi:10.1371/journal.pone.0073512.t001
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Bocillin-FL staining of PBPs
Cell membrane fractions were extracted as described above.
Eighty mg of proteins from membrane fractions were incubated for
30 min at 35uC with the fluorescent penicillin analogue Bocillin-
FL (Invitrogen) as previously described [51]. Samples were
separated by a SDS-7.5% PAGE and fluorescence was visualized
with the FluorChemTM SP imaging system (AlphaInnotech).
NaCl tolerance
Overnight cultures of strains were transferred into a single row
of a microtiter plate and serial 5-fold dilutions in 0.85% NaCl were
prepared. Dilutions were replica-plated onto increasing NaCl
concentrations using an automatic inoculator (Microtiter, Dyna-
tech AG, Switzerland). All plates were incubated at 37uC for 48 h
and three independent experiments were performed.
Luciferase assays
Luciferase measurements were performed as described earlier
[19]. Briefly, cultures were inoculated at OD 0.05 and 1 ml
samples were harvested by centrifugation after 1.5, 3, 4.5, 6 and
7.5 hours. Pellets were thawed and resuspended in PBS to OD 10.
Cell suspensions were mixed with equal amounts of Luciferase
Assay System substrate (Promega, Madison, WI, USA) and
luminescence was measured on a Turner Designs TD-20/20
luminometer (Promega). For statistical analysis of individual time
points and for comparison of whole data sets, Student’s t-test and
two-way Anova were applied, respectively.
Cell sampling for c-di-AMP quantification
Overnight cultures were diluted to OD 0.05 and grown to OD
2. Cells were harvested by filtration using 0.2 mm RC filters
(Sartorius Stedium Biotech, Go¨ttingen, Germany) collecting 3 ml
culture per filter and two filters for each of the five replicates.
Filters were washed once with 10 ml Braun water (37uC, B. Braun
Meslungen AG, Meslungen, Germany) and directly transferred
into 12 ml of pre-cooled quenching solution (–20uC, 60%
acetonitril (Sigma, CHROMASOLVH Plus), 20% methanol
(Sigma), 20% 0.5 M formic acid). Three hundred ml of 0.5 mM
c-di-GMP (Biolog, Bremen, Germany) solution were added as an
internal standard and the solution was sonicated four times for 20
seconds before it was snap frozen in liquid nitrogen and
lyophilised.
c-di-AMP analysis by LC-MS
Analyses were performed with a Rheos 2200 HPLC system
(Flux Instruments, Basel, Switzerland) coupled to an LTQ
Orbitrap mass spectrometer (Thermo Fisher Scientific, Waltham,
MA, USA), equipped with an electrospray ionisation probe. c-di-
AMP esters were analyzed by a method previously used for online
solid phase extraction (SPE) and LC-MS analysis of CoA esters
[52] with the exception of the MS analysis which was optimized
for ionization of c-di-AMP (for parameters see below). Besides
desalting, the method allowed complete removal of polar
compounds including mono-nucleotides from cell extracts and
samples could be injected at higher concentration. To perform
online SPE of c-di-AMP and c-di-GMP prior to LC separation two
C18 analytical columns (Gemini 5062.0 mm and 10062.0 mm,
particle size 3 mm; Phenomenex, Torrance, CA, USA) were used.
Flow rate was 220 ml/min, solvent A was 50 mM formic acid
adjusted to pH 8.1 with NH4OH and solvent B was methanol.
The injection volume was 10 ml. For online desalting, samples
were loaded on 5062.0 mm C18 column and the sample was
washed on column for 5 min with 100% solvent A. During SPE
the short column was connected to waste via a 6-port-valve and
the 10062.0 mm column was equilibrated with solvent A by an
additional pump. After desalting both columns were connected in
series and the following gradient of B was applied to separate c-di-
AMP: 5 min, 5%; 15 min, 23%; 25 min, 80%; 27 min, 80%. The
LC-MS system was equilibrated for 6 min at initial elution
conditions between two successive analyses. The LC was coupled
to the mass spectrometer. Sheath gas flow rate was 40, auxiliary
gas flow rate was 30, tube lens was –93 V, capillary voltage was –
35 V, and ion spray voltage was –4.0 kV. MS analysis was done in
the negative FTMS mode at a resolution of 60,000 (m/z 400).
Quantification of c-di-AMP
c-di-AMP was quantified using c-di-GMP as an internal
standard to compensate for loss during sample preparation.
Though c-di-GMP and c-di-AMP are chemically very similar, they
do not co-elute and other compounds present in the sample can
influence electrospray ionization of compounds. Therefore, the
area response factors of the two compounds were determined in a
series of standard solutions relative to the series of S. aureus cell
extracts spiked with standards. The slope of a linear calibration
curve (y =m*x+b) was determined for both compounds in
standard and in cell extracts and slope ratios (msample/mstandard)
were calculated. Values were used to correct corresponding peak
areas measured in S. aureus extracts. The detection limit of 32 nM
c-di-AMP (corresponding to 0.3 pmol c-di-AMP on the column)
was estimated from the intercept of the calibration curve.
Results and Discussion
Identification of mutation in the diadenylate cyclase
gene dacA
In previous studies a highly and homogeneously resistant
MRSA was constructed by introducing the SCCmec element from
strain COL into the methicillin sensitive S. aureus (MSSA) strain
BB255 [53,54]. Introduction of the resistance cassette caused a
fitness cost and significantly reduced the growth rate of the
resulting MRSA strain RA120. From this slow growing strain
RA120, a faster growing variant, ME51, was isolated during a
competitive growth experiment [54]. Rescue from the fitness
burden was accompanied by reduced, heterogeneous resistance to
oxacillin [54]; a phenotype observed in CA-MRSA strains [4].
Genome sequencing of these two MRSA strains, RA120 and
ME51, revealed 80 SNPs or deletion/insertion polymorphisms
(DIPs) present in both strains, compared to the published
NCTC8325 sequence (GenBank accession CP000253). Therefore,
the parent strain BB255 was subsequently sequenced, confirming
that these SNPs were already present in BB255, which excluded
the possibility that these genetic differences were connected to the
introduction of the SCCmec element (complete Table S1). All 46
sequencing errors identified in the NCTC8325 sequence by
Berscheid et al. were confirmed in BB255 [55]. Twelve SNPs and
one DIP were likely to be additional sequencing errors in the
published NCTC8325 sequence since they were present in all
other published S. aureus genomes including the NCTC8325
derivative RN4220 [56] (Table 2, marked with a cross in column
RN4220). Thus, 21 SNPs or DIPs were identified to be real
differences between BB255 and other NCTC8325 derivatives
(Table 2). These mutations could either have been naturally
acquired over time or caused by the ethidium bromide treatment
of the original NCTC8325 FK268 that was used to cure it from its
plasmid to create strain BB255 [53].
The SCCmec element introduced from strain COL was identical
in both strains RA120 and ME51, but had four SNPs and a
Effects of Reduced C-Di-AMP Levels on MRSA
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deletion when assembled against the published SCCmec sequence
of COL (GenBank accession CP000046). One mutation was found
in a glycerophosphoryl diester phosphodiesterase (COL genome
position G38611A, SACOL_0031, Asp95Asn) and one in a
conserved hypothetical protein (C51476T, SACOL_0044, Cy-
s42Tyr). In the gene of the methicillin resistance surface protein
Pls two silent SNPs (G57595A, A61354T) and a five nucleotide
deletion at position 61363-61367, leading to the loss of amino
acids and a frame shift resulting in truncation of Pls at amino acid
1383, were detected.
In addition to the SNPs and DIPs present in both strains, the
genome sequences of RA120 and ME51 differed by only one
nucleotide in the recently discovered c-di-AMP cyclase gene dacA
(SAOUHSC_02407) [29,33], which was confirmed by Sanger
sequencing. The SNP was identified in ME51, resulting in the
change of a highly conserved glycine to a serine (Gly206Ser,
Table 2. SNPs and DIPs identified in BB255, RA120 and ME51.
Position1 Ref2 Seq3 Impact Locus (SAOUHSC_)1 Description4 RN42205
5286 G A Gly85Ser 00166 DNA gyrase, ATP hydrolyzing subunite B
22181 C A Intergenic 00018/00019 Non-coding x
47652 T - Intergenic 00044/00045 Non-coding x
73564 G T Asn472Lys 00069 Partial spa gene for immunglobulin G binding
protein A
142255 G T Gly200Trp 00136 CHP, nitrate transport ATP-binding protein NrtD,
Putative ABC transporter
210632 T A Asp454Glu 00190 CHP, membrane domain of membrane-anchored
glycerophosphoryl diester phosphodiesterase
218932 C T Asp63Asn 00197 Putative acyl-CoA dehydrogenase domain protein
230630 T G Silent 00209 Putative PTS system maltose-and glucose-specific
EIICB component
252494 G A Gly323Asp 00230 Two-component sensor histidine kinase LytS
329229 T C Leu131Ser 00314 Possible transcriptional regulator MarR family,
MATE family multi-antimicrobial extrusion protein
433209 A T Intergenic 00434/00435 Non-coding
523591 G A Glu431Lys 00524 DNA-directed RNA polymerase beta subunit
541723 T G Intergenic 00535/00536 Non-coding
541724 G C Intergenic 00535/00536 Non-coding
649126 G T Silent 00661 CHP, putative lipase/esterase x
841103 G T Silent 00877 Iron-sulphur cluster assembly accessory protein x
841139 G T Silent 00877 Iron-sulphur cluster assembly accessory protein x
980692 C T Pro301Leu 01009 Phosphoribosylaminoimi-dazole carboxylase,
ATPase subunit
1013608 G A Val50Met 01044 CHP, putative transcriptional regulator
1653482 G A Silent 01748 tRNA-guanine transglycosylase x
2243145 G – R0005 rRNA-16S Ribosomal RNA
2243146 G – R0005 rRNA-16S Ribosomal RNA
2318272 G A Intergenic 002512/02515 Non-coding x
2318274 G T Intergenic 002512/02515 Non-coding x
2318290 C A Intergenic 002512/02515 Non-coding x
2331612 C A Ala30Ser 02527 Peptidoglycan pentaglycine interpeptide
biosynthetic protein FmhB (FemX)
2383630 G T Silent 02591 CHP, putative membrane protein x
2383660 G T Silent 02591 CHP, putative membrane protein x
2466536 T C Lys349Glu 02681 Nitrate reductase, alpha subunit
2556234 A G Intergenic 02781/02782 Non-coding
2596878 C T Gly107Asp 02818 MFS family major facilitator transporter
2678563 T C Silent 02911 CHP x
2684051 C T Ala90Thr 02919 3-methyl-2-oxobutanoate hydroxymethyltransferase
2689048 G T Val353Leu 02923 Amino acid permease x
1Genome positions and locus numbers are according to NCTC8325 sequence (GenBank accession CP000253). 2Reference nucleotide in NCTC8325. 3Sequenced
nucleotide in BB255, RA120 and ME51 determined in this study. 4Description of putative gene products and functions were taken from NCTC8325 annotations and were
improved from annotations of other S. aureus strains. 5x in this column indicates SNP/DIP is present in RN4220 [56]. Abbreviation: CHP, conserved hypothetical protein.
doi:10.1371/journal.pone.0073512.t002
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genome position C2235346T in NCTC8325) which is separated
by only one amino acid from the proposed functional motive RHR
of the diadenylate cyclase [33].
Reconstruction of the dacA-SNP
To confirm a direct connection between the mutation in the
dacA gene and the phenotypic changes in ME51 that resulted in it
becoming a fitter but heterogeneously resistant strain, the
mutation was artificially introduced into the homogeneously
high-level resistant but slow growing strain RA120 by homologous
recombination, resulting in strain RA120::dacA-SNP. Upon
introduction of the SNP into RA120, its resistance profile became
heterogeneous (Figure 1A) and the oxacillin MIC decreased from
.256 mg/L for RA120 to 64 mg/L for RA120::dacA-SNP. Like
ME51, strain RA120::dacA-SNP grew faster than RA120 (Figure
1B). The growth rate increased significantly (p,0.01) upon
introduction of the dacA-SNP with a reduction of the doubling
time from 39.561.7 min for RA120 to 29. 861.6 min for
RA120::dacA-SNP in the exponential growth phase. These
resistance and fitness features of RA120::dacA-SNP were compa-
rable to ME51 which had a doubling time of 29.062.1 and an
oxacillin MIC of 64 mg/L. Several recently published studies
found that mutations in the c-di-AMP phosphodiesterase gdpP
increased resistance to beta-lactam antibiotics [38,39,40,41]. The
study of Corrigan et al. quantified the c-di-AMP levels in a gdpP
mutant confirming thereby that elevated c-di-AMP levels are
associated with increased beta-lactam resistance [29]. We
hypothesized that the opposite occurred in ME51. The amino
acid substitution close to one of the functional motifs in DacA
could reduce the efficiency of the cyclase resulting in a lower c-di-
AMP level and decreased beta-lactam resistance. The growth rate
of the constructed mutant RA120::dacA-SNP increased to a level
that was comparable to that of the naturally selected mutant
ME51 (Figure 1B), suggesting a direct connection between
increased fitness and the mutation in dacA.
Quantification of c-di-AMP and penicillin binding
proteins (PBPs)
To prove our hypothesis that the dacA mutation reduces the
cellular level of c-di-AMP, LC-MS analysis of RA120, ME51 and
RA120::dacA-SNP were performed to quantify c-di-AMP. The
amount of c-di-AMP per mg cellular dry weight (cdw) was
13.861.7 ng/mg cdw for the wild type strain RA120 and
significantly reduced to 5.860.2 ng/mg cdw and 4.560.5 ng/
mg cdw for ME51 and RA120::dacA-SNP, respectively (Figure
2A). Compared to the up to 15-fold increase seen in c-di-AMP
upon gdpP mutation [29] this is a rather small decrease which,
however, had a pronounced effect on fitness and resistance.
Pozzi and co-workers showed that a heterogeneously resistant
strain was transformed into a homogeneously resistant strain that
produced increased amounts of PBP2a, upon mutation in the c-di-
AMP phosphodiesterase gdpP [41]. Thus, one explanation for a
reduction of resistance in the strains ME51 and RA120::dacA-SNP
could be a decreased level of PBP2a. However, in our strains no
significant difference in PBP2a production was detected upon dacA
mutation neither in ME51 nor in RA120::dacA-SNP (Figure 2B).
Quantification of signal intensities from PBP2a Western blots gave
values of 9666% for ME51 at OD1 and 10465% at OD 4,
relative to the signal intensity of RA120. Similar values were
detected for RA120::dacA-SNP resulting in intensity percentages of
9864% at OD 1 and 10666% at OD 4, compared to RA120. In
the study of Pozzi et al. the effect of their gdpP mutation on the c-di-
AMP level was not quantified, but it may be assumed from the
studies of Corrigan et al. that gdpP mutations have a more drastic
effect on c-di-AMP levels than the dacA-SNP identified in this
study. This could be reflected in the magnitude of PBP2a level
changes [29], and explain why we could not detect a difference in
PBP2a levels in our dacA-SNP mutants. Alternatively, the dacA-
SNP may influence methicillin resistance independently of the
amount of PBP2a. c-di-AMP was previously found to affect cell
wall homeostasis and elevated levels of c-di-AMP increased
peptidoglycan cross linking by an as yet unknown mechanism
[29,40]. These findings, together with the fact that gdpP mutations
in MSSA strain backgrounds lead to increased beta-lactam MICs
[39] and our observation of decreased oxacillin resistance in
MSSA strain BB255 upon dacA-SNP introduction (see below),
suggest that the effects of c-di-AMP on beta-lactam resistance are
likely to be at least partially independent of PBP2a levels.
However, more research is required to understand the mechanism
by which c-di-AMP affects cell wall homeostasis and beta-lactam
resistance.
Since PBP2 and PBP4 were previously shown to affect beta-
lactam resistance, the protein levels of endogenous PBPs were also
analysed [15,16,57,58]. Qualitative analysis of the amount of the
endogenous PBPs PBP1, PBP2 and PBP3 using the fluorescent
penicillin analogue Bocillin-FL did not reveal any obvious
differences between the strains RA120, ME51 and RA120::dacA-
SNP (Figure 2C). Interestingly, PBP4 Western blots showed
seemingly higher amounts of PBP4 in dacA-SNP strains ME51 and
RA120::dacA-SNP, which, however, was not significantly different
from RA120 due to large variations between experiments (Figure
2D). Quantification of Western blot signals as in percentages of the
Figure 1. Oxacillin resistance and fitness of RA120, ME51 and
RA120::dacA-SNP. A, oxacillin population analysis profiles and B,
growth curves of the strain RA120 (black squares) and the dacA-SNP
strains ME51 (white diamonds) and RA120::dacA-SNP (white squares).
Representative data from three independent experiments are shown.
doi:10.1371/journal.pone.0073512.g001
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signal intensity of RA120 gave values of 197661% and 181662%
at OD 1, and 171652% and 190658% at OD 4, respectively.
This observation was unexpected, since previous studies had
shown that PBP4 levels directly correlated with beta-lactam
resistance; overexpression of PBP4 leading to increased beta-
lactam resistance [57] and deletion of PBP4 reducing resistance
levels [16,58,59]. Even though the importance of PBP4 for beta-
lactam resistance was shown to be very strain dependent [16], we
would not have expected to see higher PBP4 levels in the dacA-
SNP strains that had reduced oxacillin MICs. However, it is
possible that despite increased total amounts, PBP4 activity or
localisation could be impaired and further research is required to
evaluate if there is a connection between c-di-AMP levels and
PBP4 levels, activity or localisation.
Cell envelope associated phenotypes of dacA-SNP
Additional effects of this more than 2-fold decrease in the
cellular c-di-AMP level were further investigated by phenotypic
characterisation of RA120 and the dacA-SNP strains ME51 and
RA120::dacA-SNP. In S. aureus, elevated c-di-AMP levels caused by
gdpP mutations were found to affect cell envelope homeostasis
resulting in increased autolysis and increased resistance to
lysostaphin and oxacillin [29]. As expected, we observed the
opposite effect in dacA-SNP strains. The dacA-SNP clearly
decreased resistance to oxacillin as shown above (Figure 1A) and
decreased both spontaneous and Triton X-100 induced autolysis
(Figure 3AB). However, resistance to lysostaphin was not affected
(data not shown).
A study in Lactococcus lactis revealed salt hypersensitivity in a
spontaneous gdpP mutant [45]. Although, S. aureus can tolerate
high salt concentrations [60], we could detect decreased salt
sensitivity in the mutants with lower c-di-AMP levels (Figure 3C).
Inversely, increased salt sensitivity was observed very recently for a
S. aureus gdpP mutant with 15-fold increased c-di-AMP levels and
for a mutant of the newly identified c-di-AMP target ktrA, a
potassium transporter-gating component [46].
Since previous studies suggest c-di-AMP to be involved in cell
envelope homeostasis and cell envelope stress [29,40] we analysed
the effect of the dacA-SNP on expression of the cell wall stress
stimulon (CWSS). Induction of the CWSS, a set of genes
controlled by the two component system VraSR, is a good
indicator of cell envelope stress caused by disturbance of cell
envelope biosynthesis [19,28,61]. CWSS expression is up-regulat-
ed by depletion or deletion of cell envelope biosynthesis enzymes
or upon exposure to cell wall-targeting antibiotics
[19,61,62,63,64,65,66]. Using the well established reporter plas-
mid psas016p-luc+ which contains the promoter of sas016, a highly
responsive CWSS gene of unknown function, fused to a luciferase
gene [65,67], the CWSS expression was measured indirectly in
relative light units (RLU). Indeed, we detected a lower basal
CWSS expression over growth in the dacA-SNP strains ME51 and
RA120::dacA-SNP (Figure 3D). The expression level in the parent
strain RA120 was about 3-fold higher than in the dacA-SNP
strains. These findings suggest that cell wall stress stimulon
expression could correlate directly with cellular c-di-AMP levels.
Effect of the dacA-SNP on fitness, resistance and c-di-
AMP levels in an MSSA strain and in an MRSA of different
genetic background
To determine the general importance of DacA in different
strain backgrounds, the dacA-SNP was introduced into the MSSA
parent strain BB255 and into the MRSA strain COL which both
carried dacA genes that were 100% identical to dacA in RA120.
Both resulting mutants showed increased oxacillin susceptibility
(Figure 4A). The number of surviving cells decreased in the
methicillin sensitive strain BB255::dacA-SNP by approximately
1000-fold on plates containing 0.125 mg/L or 0.25 mg/L of
oxacillin, which was also reflected by a reduction of the oxacillin
MIC from 0.25 mg/L in BB255 to 0.125 mg/L in BB255::dacA-
SNP. In the COL::dacA-SNP mutant a lowered and heterogeneous
resistance profile was observed, though the effect was slightly less
pronounced than in the BB255 derived MRSA RA120::dacA-SNP.
The oxacillin MIC for COL decreased from .256 mg/L to
256 mg/L upon introduction of dacA-SNP.
The impact of the dacA-SNP on fitness varied between the
different strains. The MSSA strain BB255 showed a decrease in
the growth rate upon the introduction of the dacA-SNP (Figure 4B);
the doubling time increased from 3062.1 min for BB255 to
Figure 2. Cellular levels of c-di-AMP and PBPs of RA120, ME51
and RA120::dacA-SNP. A, cellular levels of c-di-AMP quantified by LC-
MS in ng per mg cellular dry weight (cdw). Average values from five
biological replicates with standard deviation are shown. Asterisks
indicate significant differences compared to RA120 (** p,0.01). B,
PBP2a (76 kDa) Western blot analysis, C, visualisation of PBP1 (83 kDa),
PBP2 (80 kDa) and PBP3 (77 kDa) using the fluorescent penicillin
analogue Bocillin-FL and D, PBP4 (48 kDa) Western blot analysis of
membrane fractions of the strains RA120 (1), ME51 (2) and RA120::dacA-
SNP (3) sampled at indicated ODs. Representative results from three
independent protein extractions are shown.
doi:10.1371/journal.pone.0073512.g002
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4263.2 min for BB255::dacA-SNP. In COL, the SNP did not
significantly affect the minimal doubling time of the strain with 38.
261.1 min and 40.061.9 min for COL and for COL::dacA-SNP,
respectively (Figure 4C). Quantification of c-di-AMP once again
showed clear reductions in cellular c-di-AMP levels upon dacA-
SNP introduction into both backgrounds (Figure 4D). Introduction
of the dacA-SNP into MRSA COL reduced the c-di-AMP level
about four-fold, from 4.560.5 to 1.160.1 ng/mg cdw. The
induction of dacA-SNP into BB255 reduced the c-di-AMP of
2.460.3 ng/mg cdw to a level below the limit of detection. The
value included in the graph as a grey bar corresponds to the limit
of detection (32 nM) divided by samples biomass concentrations.
The reduction to a very low c-di-AMP level might be an
explanation for the reduced growth rate of BB255::dacA-SNP,
since c-di-AMP was claimed to be essential for S. aureus [29] and
reduced c-di-AMP levels were found be detrimental for growth of
B. subtilis [34] and L. monocytogenes [42].
Surprisingly, the c-di-AMP level in BB255, the RA120 parent
strain, was about 6-fold lower than the c-di-AMP level in RA120.
Therefore, it could be speculated that introduction of the SCCmec
element into BB255 led to non genetic adaptations of yet unknown
nature, resulting in an elevated c-di-AMP level in RA120, which
Figure 3. Analysis of phenotypes associated with cell envelope properties in RA120, ME51 and RA120::dacA-SNP. A, spontaneous
autolysis of RA120 (black squares) and the dacA-SNP strains ME51 (white diamonds) and RA120::dacA-SNP (white squares) in phosphate buffer and B,
induced autolysis of strains with 0.01% Triton X-100 in phosphate buffer. Average values with standard deviation from three independent
experiments are shown. Asterisks indicate measurement time points with significant difference between both RA120/ME51 and RA120/RA120::dacA-
SNP (* p,0.05, ** p,0.01) using Student’s t-test. Two-way ANOVA analysis considering all time points resulted in significant differences (p,0.01) for
stain pairs RA120/ME51 and RA120/RA120::dacA-SNP for both spontaneous and induced autolysis. C, NaCl tolerance of RA120, ME51 and
RA120::dacA-SNP. Overnight cultures were serially diluted 1:5 and plated on plain LB agar or LB agar with 2.2 M NaCl. Representative results from
three independent experiments are shown. D, left, relative light units (RLU) measured from cell wall stress stimulon reporter construct psas016p-luc+
in RA120 (black squares) and the dacA-SNP strains ME51 (white diamonds) and RA120::dacA-SNP (white squares) and right, the corresponding OD
values of the cultures at each sampling point. Average values with standard deviation from three independent experiments are shown. Asterisks
indicate measurement time points with significant differences in RLU between both RA120/ME51 and RA120/RA120::dacA-SNP strain pairs. If the
strain pairs had different categories of p-values these were indicated separately (* p,0.05, ** p,0.01). Two-way ANOVA analysis considering RLU
values from all time points resulted in significant differences (p,0.01) for both strain pairs RA120/ME51 and RA120/RA120::dacA-SNP.
doi:10.1371/journal.pone.0073512.g003
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was reduced by the dacA mutation to a wild type level in ME51
and RA120::dacA-SNP. However, to our knowledge, no studies on
the natural variation of the c-di-AMP levels in different strain
backgrounds have been performed yet and current data suggests
that c-di-AMP levels are not generally higher in MRSA, since
Corrigan et al. did not detect a difference in c-di-AMP levels
between MRSA and MSSA [29]. Thus, more work is required to
confirm and explain the possibly elevated c-di-AMP levels in
RA120 and to generally understand the mechanisms by which c-
di-AMP affects beta-lactam resistance. So far, forces driving
acquisition of mutations in c-di-AMP synthesising gene dacA or the
degrading enzyme gdpP seem to include stress caused by i) selective
pressure by beta-lactams [38,39,41] ii) disturbance of cell envelope
integrity due to LTA-deficiency [29] or iii) selective pressure on
fitness such as the conditions occurring in mixed growth
competition experiments ([54], this work). Why and how altering
c-di-AMP levels under these conditions might be an advantage for
S. aureus remains to be elucidated. As a second messenger, c-di-
AMP can be expected to control several factors involved in
different cellular processes, which might explain why alterations in
c-di-AMP levels can lead to such diverse phenotypes as changes in
antibiotic resistance, cell envelope stability, cell division, biofilm
formation, growth rate, transcription of regulators, expression of
virulence factors and pathogenicity.
Conclusion
This is the first time that a mutation in dacA, resulting in
decreased c-di-AMP levels, was shown to reduce methicillin
resistance and increase growth rates. Markerless allelic replace-
ment confirmed that the dacA mutation could transform a highly
homogenously methicillin resistant strain into a faster growing but
lower-level and heterogeneously resistant MRSA. The impact of
the dacA-SNP on c-di-AMP levels and fitness seemed to vary
between strain backgrounds. Analysis of cell envelope properties of
the strains with the dacA mutation revealed reduced autolysis,
increased salt tolerance and a reduction in the basal expression
level of the cell wall stress stimulon, providing further confirmation
for a cell envelope associated signalling function of c-di-AMP.
Further research is required to understand how cellular c-di-AMP
levels influence fitness and resistance. This will involve investigat-
ing possible connections between the phenotypes associated with
altered c-di-AMP levels and the five recently identified c-di-AMP
targets and the potential identification of additional targets of c-di-
AMP-dependent regulation.
Figure 4. Effect of dacA-SNP on oxacillin resistance, fitness and the c-di-AMP levels in MSSA strain BB255 and MRSA strain COL. A,
oxacillin population analysis profile of wild type strains BB255 (black triangle) and COL (black circle) and their corresponding dacA-SNP strains
BB255::dacA-SNP (white triangle) and COL::dacA-SNP (white circle). Representative data from three independent experiments are shown. B, growth
curves of BB255 and BB255::dacA-SNP and C, growth curves of COL and COL::dacA-SNP. Representative data from three independent experiments are
shown. D, cellular levels of c-di-AMP quantified by LC-MS in ng per mg cellular dry weight (cdw). Average values from five biological replicates with
standard deviation are shown. Grey bar with asterisk (*) indicates c-di-AMP concentration was blow detection limit and the given value represents
maximal concentration which was estimated by dividing the limit of detection (32 nM) by the samples biomass concentrations. Two asterisks (**)
indicate a significant difference using Student’s t-test (p,0.01) and the dashed bracket indicates statistical analysis was performed using the
estimated maximal value for BB255::dacA-SNP.
doi:10.1371/journal.pone.0073512.g004
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